Provenance du réseau au premier degré de Tom Baker
Entité | Type d'entité | Industrie | |
---|---|---|---|
Private Company | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tom Baker via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
University of California, Santa Barbara | College/University | Undergraduate Degree | |
The University of Colorado | College/University | Undergraduate Degree | |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Medicine in Need Corp.
Medicine in Need Corp. Internet Software/ServicesTechnology Services Medicine in Need Corp. provides pharmaceutical and nutraceutical drugs. It offers cancer and HIV drugs, chemotherapy pills, both generic and brand medicine as well as non-prescription medication. The company is headquartered in Cambridge, MA. | Internet Software/Services | Director/Board Member | |
Development Specialists, Inc.
Development Specialists, Inc. Investment ManagersFinance Development Specialists, Inc. provides investment advice. The American company was founded in 1977 by Andy Hirschberg and Bill Brandt. | Investment Managers | Corporate Officer/Principal | |
American Bankruptcy Institute
American Bankruptcy Institute Miscellaneous Commercial ServicesCommercial Services The American Bankruptcy Institute is a professional association. The non-profit company is based in Alexandria, VA. The company was founded by Richard A. Gitlin. | Miscellaneous Commercial Services | President | |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Founder | |
SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
ARVINAS, INC. | Biotechnology | Investor Relations Contact | |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Xenimmune Therapeutics, Inc.
Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xenimmune Therapeutics, Inc. develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection. The private company is located in the US. | Pharmaceuticals: Major | Founder |
Statistiques
Internationale
Etats-Unis | 18 |
Sectorielle
Health Technology | 11 |
Consumer Services | 4 |
Finance | 3 |
Technology Services | 2 |
Commercial Services | 2 |
Opérationnelle
Corporate Officer/Principal | 12 |
Undergraduate Degree | 3 |
Director/Board Member | 3 |
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Relations les plus connectées
Insiders | |
---|---|
James L. Wright | 9 |
Stephen Zale | 4 |
Jeff Boyle | 4 |
Geoffrey L. Berman | 3 |
Neil Bander | 3 |